Vort John Vander - Net Worth and Insider Trading
Vort John Vander Net Worth
The estimated net worth of Vort John Vander is at least $123,000 dollars as of 2024-11-13. Vort John Vander is the Director of Aratana Therapeutics Inc and owns about 25,000 shares of Aratana Therapeutics Inc (PETX) stock worth over $123,000. Details can be seen in Vort John Vander's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vort John Vander has not made any transactions after 2015-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vort John Vander
Vort John Vander Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vort John Vander owns 6 companies in total, including Aratana Therapeutics Inc (PETX) , Histogen Inc (HSTO) , and Epizyme Inc (EPZM) among others .
Click here to see the complete history of Vort John Vander’s form 4 insider trades.
Insider Ownership Summary of Vort John Vander
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PETX | Aratana Therapeutics Inc | 2019-07-18 | director |
| HSTO | Histogen Inc | 2013-07-24 | 10 percent owner |
| EPZM | Epizyme Inc | 2013-05-30 | 10 percent owner |
 | | 2008-06-15 | director & Secretary |
| | 2011-02-02 | 10 percent owner |
| | 2012-01-26 | other: Former 10% stockholder |
Vort John Vander Latest Holdings Summary
Vort John Vander currently owns a total of 1 stock. Vort John Vander owns 25,000 shares of Aratana Therapeutics Inc (PETX) as of March 6, 2015, with a value of $123,000.
Latest Holdings of Vort John Vander
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PETX | Aratana Therapeutics Inc | 2015-03-06 | 25,000 | 4.92 | 123,000 |
Holding Weightings of Vort John Vander
Vort John Vander Form 4 Trading Tracker
According to the SEC Form 4 filings, Vort John Vander has made a total of 0 transactions in Aratana Therapeutics Inc (PETX) over the past 5 years. The most-recent trade in Aratana Therapeutics Inc is the sale of 6,137 shares on March 6, 2015, which brought Vort John Vander around $122,801.
Insider Trading History of Vort John Vander
- 1
Vort John Vander Trading Performance
GuruFocus tracks the stock performance after each of Vort John Vander's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vort John Vander is 130.14%. GuruFocus also compares Vort John Vander's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vort John Vander within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vort John Vander's insider trading performs compared to the benchmark.
Performance of Vort John Vander
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.33 | | | | | |
| Relative Return to S&P 500(%) | 15.41 | | | | | |
Vort John Vander Ownership Network
Ownership Network List of Vort John Vander
Ownership Network Relation of Vort John Vander
Vort John Vander Owned Company Details
What does Aratana Therapeutics Inc do?
Who are the key executives at Aratana Therapeutics Inc?
Vort John Vander is the director of Aratana Therapeutics Inc. Other key executives at Aratana Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .
Aratana Therapeutics Inc (PETX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aratana Therapeutics Inc (PETX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aratana Therapeutics Inc (PETX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aratana Therapeutics Inc (PETX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aratana Therapeutics Inc Insider Transactions
Vort John Vander Mailing Address
Above is the net worth, insider trading, and ownership report for Vort John Vander. You might contact Vort John Vander via mailing address: C/o Mpm Asset Management, 200 Clarendon Street 54th Floor, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
